When it comes to matters of the heart, I am a staunch advocate of anything that prevents heart disease. If you've been a regular reader of this blog, you know I usually attend online Zoom webinars organized by the Philippine Heart Association and we always emphasize taking good care of your hearts. From someone with hypertension and diabetes, I know exactly what I'm talking about. September 29 is a significant day because it is World Heart's Day. More than just a celebration, World Heart Day was established in the hopes that it could reach more people and be able to spread awareness about the perils of heart diseases and stroke.
Sanofi recognizes that this is a unique time to be worried about heart health and learn more about the steps that should be taken to ensure risk-free living, especially under a cloud of the COVID-19 pandemic.
“It’s heartbreaking to see those with comorbidities battle a critical to severe form of the virus- forcing them to put their lives on hold, be isolated from family, friends and people who matters most to them,” Amal Makhloufi Benchouk, the Philippines Country Lead for Sanofi, shared in her opening remarks.
Statistics have shown that 7 out of 10 people are diagnosed with hypertension, and 2 out of 10 hypertension patients die. Sanofi continues to respond to the challenge of dealing with comorbidities during this time, by emphasizing the need to address the lack of awareness and limited access to cardiovascular disease management.
“Cardiovascular Disease remains the number 1 killer in the world, resulting in about 18.6 Million deaths worldwide and over 520 million people globally living with cardiovascular disease that has been disproportionately affected by the pandemic,” she remarked.
Sanofi’s mission has led them to create the Empower Hypertension Program, which aims to deliver awareness, prevention, and management to patients. The program provides enlisted patients with free coaching sessions led by nurse educators to arm them with information that tackles myths and facts about the disease, among others.
Sanofi has also partnered with Omron, a leading medical electronics company, to extend a 20% to 25% discount to patients, encouraging them to procure the technology in order to monitor their blood pressure regularly.
Sanofi remains committed to its mission to promote hypertension management at the early stages and to inspire individuals to take control of their own health.
To learn more about the program, visit www.sanofi.ph or thru their Instagram account @sanofi.ph.